INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $184.29 | 200 |
| Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $186.00 | -- |
| Sep 06, 2011 |
VP Regulatory Development and
|
VP Regulatory Development and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 200 | $11.64 | 73,659 |
| Sep 06, 2011 |
VP Regulatory Development and
|
VP Regulatory Development and | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $63.52 | 73,459 |
| Sep 06, 2011 |
VP Regulatory Development and
|
VP Regulatory Development and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 200 | -- | 15,963 |
| Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 224 | $177.43 | 11,276 |
| Feb 03, 2010 |
VP Regul Devel & Med Safety
|
VP Regul Devel & Med Safety | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 291 | $28.02 | 69,799 |
| Sep 06, 2011 |
VP Regulatory Development and
|
VP Regulatory Development and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 300 | $11.64 | 73,759 |
| Sep 06, 2011 |
VP Regulatory Development and
|
VP Regulatory Development and | Form 4 | Open market or private sale of non-derivative or derivative security | 300 | $62.76 | 73,459 |
| Sep 06, 2011 |
VP Regulatory Development and
|
VP Regulatory Development and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 300 | -- | 16,163 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.